HIPEC
Study Novel Targets and Immune Biomarkers from Patients with Peritoneal Metastasis under Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Gastric Cancer
To collect patient specimens prior to and after HIPEC procedure, along with gastric cancer samples that are from non-HIPEC procedures to test for novel therapeutic additions to the current standard of care procedures. The focus is to find potential targets by studying the characteristics of the disease metastasis which will allow for better treatment options in the future.